Please find below articles from authors from Slovenia and co-authors that were published in the European Journal of Neurology

On 31 January 2019 , the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Ajovy©, intended for prophylaxis of migraine. The applicant for this medicinal product is Teva GmbH. The active substance is fremanezumab which is an antibody that works by binding to calcitonin gene-related peptide (CGRP). It is classified as an analgesic.

The 2019 Congress of the Academy for Multidisciplinary Neurotraumatology took place between April 11-12 in Cluj-Napoca, Romania, organized by the Foundation of the Society for the Study of Neuroprotection and Neuroplasticity and its partners.

On 21 March (Madrid, Spain), the new Innovative Medicines Initiative (IMI) coordination and support action entitled “Efficiently Networking European Neurodegeneration Research” (NEURONET) held its kick-off meeting.

The BioMed Alliance has provided feedback to the public consultation on Plan S, the initiative of the European Commission, Research Funding Organisations and Science Europe to promote open access publishing.

Sharing #LifeGoals has become a popular trend on social media. A campaign from the European Federation of Neurological Associations (EFNA) is putting a new spin on the trend by instead seeing patient advocates and supporters share their #BrainLifeGoals.

On Tuesday, April 9, 2019, Active Citizenship Network (ACN) celebrated the 13th European Patients’ Rights Day (EPRD).

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Oslo 2019. Please find their answers below!

Fragile X Syndrome (FXS), the most common genetic form of intellectual disability in males is caused by a ...

Awareness of atypical features in optic neuritis is crucial to initiate appropriate treatment and prevent permanent visual loss.

Whether small fiber pathology accounts for pain in fibromyalgia, and whether brain imaging can be used as an objective marker of pain remain controversial and will be discussed during the next EAN congress in Oslo.

The May issue of the European Journal of Neurology is online!

A new conceptual approach for rehabilitation biomarkers in Traumatic Brain Injury

This single centre retrospective study identifies the piriform gyrus as a crucial part in successful epilepsy surgery of temporal lobe epilepsy (TEL).

Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat.